FindTrial
Sign In

Study on postoperative nausea and vomiting of high risk emetic lung cancer treated by acupuncture stimulation at different time

Study on postoperative nausea and vomiting of high risk emetic lung cancer treated by acupuncture stimulation at different time

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100050829
Enrollment
Unknown
Registered
2021-09-04
Start date
2021-10-08
Completion date
Unknown
Last updated
2022-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

Control group:Routine nursing
Preoperative thumb-tack needle group:Preoperative thumb-tack needle on the basis of routine nursing
Postoperative thumb-tack needle group:Postoperative thumb-tack needle on the basis of routine nursing

Sponsors

Tianjin Medical University Cancer Institute and Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Histopathological diagnosis of lung cancer or highly suspected lung cancer; 2. Aged >= 18 years, and patients who underwent radical mastectomy for the first time; 3. Three specific risk factors for vomiting (female, non-smoker, history of PONV/motion sickness); 4. No previous experience in acupuncture and other acupoint massage; 5. Normal spirit and have a certain ability to ditch; 6. Can follow the guidance of the research plan; 7. ASA was stage I or II.

Exclusion criteria

Exclusion criteria: 1. Puncture site is red and swollen, ulceration, purpura, scar, etc., which is not suitable for acupuncture; 2. Skin allergy to alcohol or other substances; 3. Have hemorrhagic disease; 4. Patients who need antiemetic drugs before surgery; 5. Gastrointestinal diseases may cause nausea and vomiting; 6. Women in lactation or pregnancy; 7. Wear cochlear implants; 8. Patients receiving chemotherapy 1 month before surgery; 9. Long-term use of opioids.

Design outcomes

Primary

MeasureTime frame
Incidence of nausea and vomiting;Classification of nausea and vomiting;Frequency of nausea and vomiting;Number of times antiemetic drugs were used;Duration of nausea and vomiting;Serotonin levels;—

Secondary

MeasureTime frame
Atelectasis occurs;The first time to go underground;Pain score;Plasma gastrin levels;Absolute lymphocyte count;Postoperative chest tube extraction time;Anxiety state;Evaluation of nausea and vomiting symptoms;Safety evaluation;—

Countries

China

Contacts

Public ContactLi Yan

Tianjin Medical University Cancer Institute and Hospital

liyan1@tjmuch.com+86 18622221262

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026